Therapeutic vaccination in chronic hepatitis B
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.17, sa.1, ss.72-76, 2002 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 1
- Basım Tarihi: 2002
- Doi Numarası: 10.1046/j.1440-1746.2002.02652.x
- Dergi Adı: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.72-76
- Anahtar Kelimeler: chronic hepatitis B, interferon-alpha, treatment, vaccine, E-ANTIGEN, SURFACE-ANTIGEN, TRANSGENIC MICE, VIRUS, LAMIVUDINE, INTERFERON, ALPHA, RESPONSIVENESS, DETERMINANT, MECHANISM
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Aims: The aim was to test the efficacy of a pre-S2-containing vaccine (Genhevac-B) in chronic hepatitis B (CHB). Twenty-five naive patients (22 male, three female; median age 35; range: 6-69 years) with CHB were recruited. The inclusion criteria were: hepatitis B e antigen (HBeAg) positive or HBV-DNA detectable with liquid hybridization; alanine aminotransferase (ALT) is at least 1.5-fold the upper normal limit and histological evidence of chronic hepatitis.